EPS Bio Technology

EPS Bio Technology P/FCF

The P/FCF (Price-to-Free-Cash-Flow Ratio) of EPS Bio Technology (4183.TWO) as of Oct 16, 2026 is -16.30. In the previous year, P/FCF (Price-to-Free-Cash-Flow Ratio) was -8.15 — a change of 100.07% (lower).

P/FCF

-16.30

YoY

100.07%

Last updated:

P/FCF (Price-to-Free-Cash-Flow Ratio) of EPS Bio Technology is 2025 -16.30 . P/FCF (Price-to-Free-Cash-Flow Ratio) of EPS Bio Technology was 2024 -8.15 . It decreases by 100.07% lower compared to the previous year.

The EPS Bio Technology P/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/FCF
Date
P/FCF
Jan 1, 2018
-128.95 TWD
Jan 1, 2019
56.89 TWD
Jan 1, 2020
5.22 TWD
Jan 1, 2021
19.09 TWD
Jan 1, 2022
-38.25 TWD
Jan 1, 2023
8.33 TWD
Jan 1, 2024
-8.15 TWD
Jan 1, 2025
-16.30 TWD
The EPS Bio Technology P/FCF history
YEARP/FCFYoY
-16.30+100.07%
-8.15-197.74%
8.33-121.79%
-38.25-300.35%
19.09+265.62%
5.22-90.82%
56.89-144.11%
-128.95-1,101.29%
12.88+22.70%
10.50+35.34%
7.76-132.90%
-23.57—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

EPS Bio Technology Stock analysis

What does EPS Bio Technology do? EPS Bio Technology Corp, listed on the Taiwan Stock Exchange with ticker 4183.TWO and ISIN TW0004183009, is headquartered in Baoshan, Taiwan. The company operates within the Health Care sector, specifically in the Health Care industry. It has a workforce of 123 employees. EPS Bio Technology Corp completed its initial public offering (IPO) on November 13, 2012. The company's primary business activities involve the development and manufacture of blood glucose monitoring systems, as well as the development and sales of various medical and related medical equipment. Its main product lines include blood glucose testers, blood glucose test strips, and electric breast pumps. The firm primarily distributes its products to international markets, with a focus on Europe, North America, and other regions in Asia. The company's official website is http://www.epsbio.com.tw/. EPS Bio Technology Corp does not disclose specific financial figures or additional details about its operations beyond the provided information. The company is based in Baoshan, Hsinchu, though the source description mentions Hsinchu as the headquarters location, which is consistent with the city provided in the data. The company's operations are centered around medical technology, with an emphasis on diagnostic and consumer health products. EPS Bio Technology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EPS Bio Technology stock

P/FCF (Price-to-Free-Cash-Flow Ratio) of EPS Bio Technology is -16.30 in 2025.

P/FCF (Price-to-Free-Cash-Flow Ratio) of EPS Bio Technology changed from -8.15 to -16.30, representing a 100.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/FCF (Price-to-Free-Cash-Flow Ratio) EPS Bio Technology since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Free-Cash-Flow ratio measures how much investors pay for each unit of free cash flow. A lower ratio may indicate better value.

P/FCF = Market Capitalization / Free Cash Flow

To evaluate P/FCF (Price-to-Free-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/FCF (Price-to-Free-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/FCF (Price-to-Free-Cash-Flow Ratio)'s EPS Bio Technology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — EPS Bio Technology

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — EPS Bio Technology